New Parp Inhibitor Lynparza May Be Important Tool for Treating Early-Stage Breast Cancer

Northern Charitable Foundation - breast cancer research

The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact on the treatment and decision paths of patients with both high-risk and early-stage breast cancer. The study also showed that Lynparza reduces the chances that patients with the BRCA gene … Read more

Exploring Byron Katie’s ‘The Work’

Byron Katie

Can a Self-Inquiry Technique Help Breast Cancer Survivors? In 1986 Byron Katie developed a self-inquiry method that showed great potential for improving emotional and physical wellbeing. It’s called ‘The Work’ and is described by many as a simple yet powerful process. A recent study published by the European Journal of Integrative Medicine sought to establish … Read more